Security & Strategic Review June 2011 (ISSN 1741-4202)
MEXICO-US: No way of assessing results in major programmes
A string of official assessments has been drawing attention to shortcomings in the oversight of US anti-drugs efforts. There are mechanisms lacking to evaluate results in such areas as the use of private contractors handling more than US$3bn and the drive to curb the outflow of proceeds from the drugs trade.
End of preview - This article contains approximately 550 words
Subscribers: Log in now to read the full article
Not a Subscriber?
Enquire Now